Pacific Biosciences dba PacBio has filed a notice of an exempt offering of securities to raise $85 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Pacific Biosciences dba PacBio is raising $85,000,000.00 in new funding. Sources indicate that as part of senior management Executive, Susan Barnes played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Pacific Biosciences dba PacBio
At PacBio, were devoted to empowering you. Pioneering the future through biology takes vision. You have to look beyond the status quo to what’s possible. We know your vision can reveal the full potential of the genome, advance human health and the health of our planet. And that is why your vision and pursuit are at the very center of what our company does our product design, our customer support model, our partnerships, and even our identity. We create the worlds most advanced sequencing systems to provide you the most complete and accurate view of genomes, transcriptomes, and epigenomes. Our founders invented a new way to study the synthesis and regulation of DNA, RNA, and proteins. Driven by a desire to advance human health, were harnessing advances in biochemistry, optics, nanofabrication, and more. We are passionate about developing products that empower scientists to explore the full spectrum of genetic variation in any organism from unraveling the mystery of rare diseases to improving the worlds food supply. With world-class service and support, we keep your research progressing so you can focus on finding answers. We encourage you to see the whole picture and consider us the partner you trust to see it too.
To learn more about Pacific Biosciences dba PacBio, visit http://www.pacb.com/
Contact:
Susan Barnes, Executive
650-521-8000
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.